NEW YORK (GenomeWeb News) — Qiagen said yesterday that it will distribute Whatman's FTA DNA-handling products under a non-exclusive agreement.
 
Under the agreement, Qiagen will pay an upfront fee and royalties for the rights to sell the kits in the life science research, molecular diagnostics, and applied-testing markets.
 
The royalty payments will apply to all Qiagen sales that incorporate Whatman's products.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.